| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/07/2009 | US20090118348 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 05/07/2009 | US20090118328 Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg-Coa Reductase |
| 05/07/2009 | US20090118252 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118251 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118250 Pharmaceutical composition |
| 05/07/2009 | US20090118247 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 05/07/2009 | US20090118246 Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods |
| 05/07/2009 | US20090118241 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates |
| 05/07/2009 | US20090118218 Biocompatible Hydrogels |
| 05/07/2009 | US20090118215 Bioresorbable Controlled-Release Composition |
| 05/07/2009 | US20090117657 Preparation For Transferring Nucleic Acid Into Cell |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117196 A method for embolization by administering crosslinked polyvinylalcohol microspheres substantially spherical, sterile, and having any excess aldehyde on surfaces neutralized by an aminoalcohol; antitumor agents; hemostatic agents; analgesics; surgery; biocompatability; nontoxic; antiagglomerants |
| 05/07/2009 | US20090117195 Hydrophilic Particles Based on Cationic Chitosan Derivatives |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090117182 Intraorally rapidly disintegrating tablet |
| 05/07/2009 | US20090117174 Modified sorbitan siloxane compositions and use thereof |
| 05/07/2009 | US20090117143 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
| 05/07/2009 | US20090117126 Neutralising Antibody Molecules Having Specificity for Human IL-17 |
| 05/07/2009 | US20090117092 Collagenolytic active enzyme containing compositions, and their use in the dental field |
| 05/07/2009 | US20090117075 Temperature Responsive Delivery Systems |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE102007052871A1 Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen Capsule for holding pharmaceutical drug formulations |
| 05/07/2009 | DE102007051914A1 Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel A process for preparing loaded with growth factors, as well as particles, the particles thus obtained |
| 05/07/2009 | CA2712970A1 Lipoxin a4 protection for retinal cells |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2704262A1 Ingestible film composition |
| 05/07/2009 | CA2704162A1 Chitosan composition |
| 05/07/2009 | CA2704117A1 Transdermal delivery system |
| 05/07/2009 | CA2704116A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | CA2704054A1 Vancomycin and teicoplanin anhydrous formulations for topical use |
| 05/07/2009 | CA2704024A1 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
| 05/07/2009 | CA2703946A1 A new class of therapeutics that enhance small molecule diffusion |
| 05/07/2009 | CA2703918A1 Novel antiretroviral combination |
| 05/07/2009 | CA2703838A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | CA2702761A1 Non-aqueous water-miscible materials as vehicles for drug delivery |
| 05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
| 05/06/2009 | EP2055315A1 Thickening agent and its application |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055309A1 Vancomycin and Teicoplanin anhydrous formulations for topical use |
| 05/06/2009 | EP2055305A1 External preparation comprising prostaglandin derivative |
| 05/06/2009 | EP2055304A1 Stabilized pharmaceutical composition |
| 05/06/2009 | EP2055303A2 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 05/06/2009 | EP2055301A1 Solid oral dosage forms comprising valsartan |
| 05/06/2009 | EP2055300A2 Medicament comprising a C11-C21 alkanoic, alkenoic or alkynoic acid ester and a catechin |
| 05/06/2009 | EP2054521A2 Methods for the purification of polypeptide conjugates |
| 05/06/2009 | EP2054339A2 Particles for delivery of active ingredients, process of making and compositions thereof |
| 05/06/2009 | EP2054086A1 A conjugate of an antibody against ccr5 and an antifusogenic peptide |
| 05/06/2009 | EP2054085A2 Nanoparticle nucleic acid bonding compound conjugates forming i-motifs |
| 05/06/2009 | EP2054084A1 Aerosol formulation for the inhalation of beta agonists |
| 05/06/2009 | EP2054073A1 Pharmaceutical compositions for sustained release delivery of peptides |
| 05/06/2009 | EP2054033A2 Liquid preparation |
| 05/06/2009 | EP2054032A2 Flowable carrier matrix |
| 05/06/2009 | EP2053918A2 Synthesis of propyl phenoxy ethers and use as delivery agents |
| 05/06/2009 | EP2002828A9 Solid pharmaceutical preparation |
| 05/06/2009 | EP1879568B1 Stable pharmaceutical compositions of platinum (ii) antitumour agents |
| 05/06/2009 | EP1861073B1 Process for the production of calcium compositions in a continuous fluid bed |
| 05/06/2009 | EP1827500B1 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 05/06/2009 | EP1628683B1 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 05/06/2009 | EP1521593B1 Transdermal botulinum toxin compositions |
| 05/06/2009 | EP1478398B1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors |
| 05/06/2009 | EP1474174B1 Composition for oral or rectal administration |
| 05/06/2009 | EP1458355B1 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 05/06/2009 | EP1430074B1 Aminoglycoside lipid derivatives for transfection |
| 05/06/2009 | EP1420759B1 Pharmaceutical compositions for the treatment of asthma |
| 05/06/2009 | EP1385480B1 Liposomes |
| 05/06/2009 | EP1363933B1 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
| 05/06/2009 | EP1283724B1 Systems and methods for topical treatment with nitric oxide |
| 05/06/2009 | EP1235562B1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 05/06/2009 | EP1190706B1 Liposomes |
| 05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | EP0935417B1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 05/06/2009 | EP0697881B2 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 05/06/2009 | CN101426904A Cancerous disease modifying antibodies 141205-05 |
| 05/06/2009 | CN101426533A Immunostimulatory compositions and methods |
| 05/06/2009 | CN101426532A In vivo cell surface engineering |
| 05/06/2009 | CN101426531A Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| 05/06/2009 | CN101426530A Wound healing polymer compositions and methods for use thereof |
| 05/06/2009 | CN101426529A PEG-poly(ortho ester) graft copolymers and pharmaceutical compositions |
| 05/06/2009 | CN101426511A Chemically-modified progenipoietin conjugates |
| 05/06/2009 | CN101426504A Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom |
| 05/06/2009 | CN101426487A Formulations containing amide derivatives of carboxylic acidnsaids for topical administration to the eye |
| 05/06/2009 | CN101426466A Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101422618A Preparation technique of swine influenza DNA vaccine PLGA microspheres |
| 05/06/2009 | CN101422615A Oridonin polymer micelle administration preparation and preparation method thereof |
| 05/06/2009 | CN101422614A Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 05/06/2009 | CN101422613A Anti-cancer medicine containing low anticoagulant property heparin and taxol |
| 05/06/2009 | CN101422612A Method for increasing crocetin water solubility |
| 05/06/2009 | CN101422611A Compound preparation and preparation method thereof |
| 05/06/2009 | CN101422610A Chemical composite preparation and use thereof |
| 05/06/2009 | CN101422606A Livestock Asia I type foot-and-mouth disease virus resistance genetic engineering polypeptide vaccine and preparation method thereof |
| 05/06/2009 | CN101422586A Cataplasm for treating cervical spondylosis and preparation technique thereof |
| 05/06/2009 | CN101422578A Health-care preparation capable of removing the blood heat and stasis to remove acne and whiten and moisten the skin |
| 05/06/2009 | CN101422569A Health-care preparation capable of increasing the multiplication function of marrow hemopoietic stem cells to fight against senium and anaemia |
| 05/06/2009 | CN101422549A Traditional Chinese medicine external preparation capable of improving ascites due to cirrhosis and preparation method thereof |